Close

RedHill Biopharma (RDHL) Posts Q1 Loss of 5c/Share

April 30, 2015 7:11 AM EDT

RedHill Biopharma (NASDAQ: RDHL) reported Q1 EPS of ($0.05), $0.42 better than the analyst estimate of ($0.47).

For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings